Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov;11(11):4408-4427.
doi: 10.21037/jtd.2019.10.65.

Management of chronic obstructive pulmonary disease-A position statement of the South African Thoracic Society: 2019 update

Mohamed Sabeer Abdool-Gaffar  1 , Gregory Calligaro  2 , Michelle Lianne Wong  3 , Clifford Smith  4 , Umesh Gangaram Lalloo  5 , Coenraad Frederik Nicolaas Koegelenberg  6 , Keertan Dheda  2   7   8 , Brian William Allwood  6 , Akhter Goolam-Mahomed  9 , Richard Nellis van Zyl-Smit  2
Affiliations
Review

Management of chronic obstructive pulmonary disease-A position statement of the South African Thoracic Society: 2019 update

Mohamed Sabeer Abdool-Gaffar et al. J Thorac Dis. 2019 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: RN van Zyl-Smit has received honoraria for academic talks and advisory boards from Astra Zeneca, GSK, ASPEN, Novartis, Cipla, MSD, Roche, Pfizer, Adcock Ingram. MS Abdool-Gaffar has received honoraria for talks from Novartis, Astra Zeneca, GSK/Aspen and Pfizer. C Smith has received honoraria for academic talks and advisory boards from Astra Zeneca, GSK/Aspen, Novartis, Cipla. CF Koegelenberg has received honoraria for academic talks and advisory boards from Astra Zeneca. K Dheda has received honoraria for academic symposia, membership of advisory boards, and/ or grant support from Astra Zeneca, GSK, Novartis, Adcock Ingram, Nycomed Takeda, Cipla, and MSD. B Allwood has received honoraria for academic talks from Novartis. A Goolam-Mahomed has received honoraria for Academic talks, advisory boards and congress attendance from Astra-Zeneca and GSK-Aspen. ML Wong has received honoraria for academic talks from AstraZeneca, Cipla, Novartis, Boehringer-Ingelheim, MSD. UG Lalloo has received honoraria for academic symposia, membership of advisory boards for Astra-Zeneca, Aspen GSK, CIPLA, Novartis, Adcock Ingram, Nycomed Takeda and MSD. G Calligaro has received honoraria for academic talks from Astra-Zeneca, Novartis.

Figures

Figure 1
Figure 1
Modified Medical Research Council (UK) dyspnoea scale.
Figure 2
Figure 2
CAT is reproduced with permission from GSK.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available online: http://www.goldcopd.org/uploads/users/files/GOLD_Report2019.pdf2019
    1. Bateman ED, Feldman C, O'Brien J, et al. Guideline for the management of chronic obstructive pulmonary disease (COPD): 2004 revision. S Afr Med J 2004;94:559-75. - PubMed
    1. Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health 2015;5:020415. 10.7189/jogh.05.020415 - DOI - PMC - PubMed
    1. Adeloye D, Basquill C, Papana A, et al. An estimate of the prevalence of COPD in Africa: a systematic analysis. COPD 2015;12:71-81. 10.3109/15412555.2014.908834 - DOI - PubMed
    1. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50. 10.1016/S0140-6736(07)61377-4 - DOI - PubMed